Jennifer Jager

Jennifer Jager

Auto-generated profile, based on publicly available information

Jennifer Jager

Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and The Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Endocrinology
Verified
Journal Article
Open access
PDF file
JJJennifer Jager
Jennifer Jager
TGThierry Grémeaux
Thierry Grémeaux
MCMireille Cormont
Mireille Cormont
YMYannick Le Marchand-Brustel
Yannick Le Marchand-Brustel
Jean-françois TantiJean-françois Tanti
Jean-françois Tanti
Inflammation is associated with obesity and insulin resistance. Proinflammatory cytokines produced by adipose tissue in obesity could alter insulin signaling and action. Recent studies have shown a relationship between IL-1β level and metabolic syndrome or type 2 diabetes. However, the ability of IL-1β to alter insulin signaling and action remains to be explored. We demonstrated that IL-1β slightly increased Glut 1 translocation and basal glucose uptake in 3T3-L1 adipocytes. Importantly, we found that prolonged IL-1β treatment reduced the insulin-induced glucose uptake, whereas an acute treatment had no effect. Chronic treatment with IL-1β slightly decreased the expression of Glut 4 and markedly inhibited its translocation to the plasma membrane in response to insulin. This inhibitory effect was due to a decrease in the amount of insulin receptor substrate (IRS)-1 but not IRS-2 expression in both 3T3-L1 and human adipocytes. The decrease in IRS-1 amount resulted in a reduction in its tyrosine phosphorylation and the alteration of insulin-induced protein kinase B activation and AS160 phosphorylation. Pharmacological inhibition of ERK totally inhibited IL-1β-induced down-regulation of IRS-1 mRNA. Moreover, IRS-1 protein expression and insulin-induced protein kinase B activation, AS160 phosphorylation, and Glut 4 translocation were partially recovered after treatment with the ERK inhibitor. These results demonstrate that IL-1β reduces IRS-1 expression at a transcriptional level through a mechanism that is ERK dependent and at a posttranscriptional level independently of ERK activation. By targeting IRS-1, IL-1β is capable of impairing insulin signaling and action, and could thus participate in concert with other cytokines, in the development of insulin resistance in adipocytes.

1 April 2012 in Genes & Development
Verified
Journal Article
Open access
PDF file
ABAnne Bugge
Anne Bugge
DFDan Feng
Dan Feng
LELogan J. Everett
Logan J. Everett
EBErika R. Briggs
Erika R. Briggs
SMShannon E. Mullican
Shannon E. Mullican
MLMitchell Avery Lazar
Mitchell Avery Lazar
The nuclear receptor Rev-erbα regulates circadian rhythm and metabolism, but its effects are modest and it has been considered to be a secondary regulator of the cell-autonomous clock. Here we report that depletion of Rev-erbα together with closely related Rev-erbβ has dramatic effects on the cell-autonomous clock as well as hepatic lipid metabolism. Mouse embryonic fibroblasts were rendered arrhythmic by depletion of both Rev-erbs. In mouse livers, Rev-erbβ mRNA and protein levels oscillate with a diurnal pattern similar to that of Rev-erbα, and both Rev-erbs are recruited to a remarkably similar set of binding sites across the genome, enriched near metabolic genes. Depletion of both Rev-erbs in liver synergistically derepresses several metabolic genes as well as genes that control the positive limb of the molecular clock. Moreover, deficiency of both Rev-erbs causes marked hepatic steatosis, in contrast to relatively subtle changes upon loss of either subtype alone. These findings establish the two Rev-erbs as major regulators of both clock function and metabolism, displaying a level of subtype collaboration that is unusual among nuclear receptors but common among core clock proteins, protecting the organism from major perturbations in circadian and metabolic physiology.


26 June 2015 in Science
Verified
Journal Article
Closed access
PDF file
YZYuxiang Zhang
Yuxiang Zhang
BFBin Fang
Bin Fang
MEMatthew J. Emmett
Matthew J. Emmett
MDManashree Damle
Manashree Damle
ZSZheng Sun
Zheng Sun
MLMitchell Avery Lazar
Mitchell Avery Lazar
Multitasking around the clock: Chronic disruption of our circadian rhythms—for example, through shift work—may increase the risk of metabolic disease. Zhang et al. found that a multitasking transcription factor called Rev-erb-α regulates expression of both clock and metabolic genes through distinct mechanisms. At clock genes, it binds directly to a specific DNA sequence, displacing a competing transcription factor. At metabolic genes, it interacts not with DNA but with other transcription factors that regulate metabolic gene expression in a tissue-specific manner. Science , this issue p. 1488

1 November 2014 in Cell
Verified
Journal Article
Closed access
BFBin Fang
Bin Fang
LELogan J. Everett
Logan J. Everett
JJJennifer Jager
Jennifer Jager
EBErika Briggs
Erika Briggs
SASean M. Armour
Sean M. Armour
MLMitchell Avery Lazar
Mitchell Avery Lazar

1 January 2013 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
Jean-françois TantiJean-françois Tanti
Jean-françois Tanti
FCFranck Ceppo
Franck Ceppo
JJJennifer Jager
Jennifer Jager
FBFlavien Berthou
Flavien Berthou
Obesity is characterized by the development of a low-grade chronic inflammatory state in different metabolic tissues including adipose tissue and liver. This inflammation develops in response to an excess of nutrient flux and is now recognized as an important link between obesity and insulin resistance. Several dietary factors like saturated fatty acids and glucose as well as changes in gut microbiota have been proposed as triggers of this metabolic inflammation through the activation of pattern-recognition receptors (PRRs), including Toll-like receptors (TLR), inflammasome, and nucleotide oligomerization domain (NOD). The consequences are the production of pro-inflammatory cytokines and the recruitment of immune cells such as macrophages and T lymphocytes in metabolic tissues. Inflammatory cytokines activate several kinases like IKKβ, mTOR/S6 kinase, and MAP kinases as well as SOCS proteins that interfere with insulin signaling and action in adipocytes and hepatocytes. In this review, we summarize recent studies demonstrating that PRRs and stress kinases are important integrators of metabolic and inflammatory stress signals in metabolic tissues leading to peripheral and central insulin resistance and metabolic dysfunction. We discuss recent data obtained with genetically modified mice and pharmacological approaches suggesting that these inflammatory pathways are potential novel pharmacological targets for the management of obesity-associated insulin resistance.